Postoperative Residual Neuromuscular Paralysis at an Australian Tertiary Children’s Hospital

<div class="floats-full-page floats-full-page-other"><h2>Table 1</h2><div class="floats-full-page-caption">Patient characteristics (ASA: American Society of Anesthesiology, NMBA: neuromuscular blocking agent); total <svg height="6.20645pt" id="M2" style="vertical-align:-0.2063999pt" version="1.1" viewbox="-0.0498162 -6.00005 6.78059 6.20645" width="6.78059pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"><path d="M504 89L488 119C453 85 428 69 416 69C408 69 405 75 412 102L462 304C492 438 460 451 436 451S388 441 356 423C311 397 229 336 170 256H168L189 340C208 418 200 451 177 451C144 451 82 413 24 352L40 322C65 345 98 369 108 369C114 369 119 363 112 335L28 -3L36 -12C54 -3 83 4 112 10C125 73 138 122 153 174C205 258 328 382 376 382C395 382 399 369 384 305L330 93C312 25 323 -12 351 -12C378 -12 439 21 504 89Z" id="g50-111"></path><glyph.data ascent="3443" descent="-2856" horiz-adv-x="512" vert-adv-y="512"></glyph.data></g></svg> = 64.</div><div class="floats-full-page-content"><table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr /></td></tr><tr><td align="left" rowspan="3">ASA category (<svg height="6.20645pt" id="M3" style="vertical-align:-0.2063999pt" version="1.1" viewbox="-0.0498162 -6.00005 6.78059 6.20645" width="6.78059pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"><path d="M504 89L488 119C453 85 428 69 416 69C408 69 405 75 412 102L462 304C492 438 460 451 436 451S388 441 356 423C311 397 229 336 170 256H168L189 340C208 418 200 451 177 451C144 451 82 413 24 352L40 322C65 345 98 369 108 369C114 369 119 363 112 335L28 -3L36 -12C54 -3 83 4 112 10C125 73 138 122 153 174C205 258 328 382 376 382C395 382 399 369 384 305L330 93C312 25 323 -12 351 -12C378 -12 439 21 504 89Z" id="g50-111"></path><glyph.data ascent="3443" descent="-2856" horiz-adv-x="512" vert-adv-y="512"></glyph.data></g></svg>)</td><td align="left">I: 34</td></tr><tr><td align="left">II: 20</td></tr><tr><td align="left">III: 10</td></tr><tr><td align="center" colspan="2"><hr /></td></tr><tr><td align="left" rowspan="7">Procedure (<svg height="6.20645pt" id="M4" style="vertical-align:-0.2063999pt" version="1.1" viewbox="-0.0498162 -6.00005 6.78059 6.20645" width="6.78059pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"><path d="M504 89L488 119C453 85 428 69 416 69C408 69 405 75 412 102L462 304C492 438 460 451 436 451S388 441 356 423C311 397 229 336 170 256H168L189 340C208 418 200 451 177 451C144 451 82 413 24 352L40 322C65 345 98 369 108 369C114 369 119 363 112 335L28 -3L36 -12C54 -3 83 4 112 10C125 73 138 122 153 174C205 258 328 382 376 382C395 382 399 369 384 305L330 93C312 25 323 -12 351 -12C378 -12 439 21 504 89Z" id="g50-111"></path><glyph.data ascent="3443" descent="-2856" horiz-adv-x="512" vert-adv-y="512"></glyph.data></g></svg>)</td><td align="left">General: 24</td></tr><tr><td align="left">&#13;
                Orthopedic: 7</td></tr><tr><td align="left">Urology: 11</td></tr><tr><td align="left">ENT: 5</td></tr><tr><td align="left">Plastics: 4</td></tr><tr><td align="left">Eye: 2</td></tr><tr><td align="left">Other: 11 </td></tr><tr><td align="center" colspan="2"><hr /></td></tr><tr><td align="left" rowspan="2">Urgency (<svg height="6.20645pt" id="M5" style="vertical-align:-0.2063999pt" version="1.1" viewbox="-0.0498162 -6.00005 6.78059 6.20645" width="6.78059pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"><path d="M504 89L488 119C453 85 428 69 416 69C408 69 405 75 412 102L462 304C492 438 460 451 436 451S388 441 356 423C311 397 229 336 170 256H168L189 340C208 418 200 451 177 451C144 451 82 413 24 352L40 322C65 345 98 369 108 369C114 369 119 363 112 335L28 -3L36 -12C54 -3 83 4 112 10C125 73 138 122 153 174C205 258 328 382 376 382C395 382 399 369 384 305L330 93C312 25 323 -12 351 -12C378 -12 439 21 504 89Z" id="g50-111"></path><glyph.data ascent="3443" descent="-2856" horiz-adv-x="512" vert-adv-y="512"></glyph.data></g></svg>)</td><td align="left">&#13;
                Elective: 44</td></tr><tr><td align="left">Urgent: 20</td></tr><tr><td align="center" colspan="2"><hr /></td></tr><tr><td align="left" rowspan="4">NMBA on induction (<svg height="6.20645pt" id="M6" style="vertical-align:-0.2063999pt" version="1.1" viewbox="-0.0498162 -6.00005 6.78059 6.20645" width="6.78059pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"><path d="M504 89L488 119C453 85 428 69 416 69C408 69 405 75 412 102L462 304C492 438 460 451 436 451S388 441 356 423C311 397 229 336 170 256H168L189 340C208 418 200 451 177 451C144 451 82 413 24 352L40 322C65 345 98 369 108 369C114 369 119 363 112 335L28 -3L36 -12C54 -3 83 4 112 10C125 73 138 122 153 174C205 258 328 382 376 382C395 382 399 369 384 305L330 93C312 25 323 -12 351 -12C378 -12 439 21 504 89Z" id="g50-111"></path><glyph.data ascent="3443" descent="-2856" horiz-adv-x="512" vert-adv-y="512"></glyph.data></g></svg>)</td><td align="left">Atracurium: 41</td></tr><tr><td align="left">Rocuronium: 15</td></tr><tr><td align="left">Succinylcholine: 6</td></tr><tr><td align="left">Vecuronium: 1</td></tr><tr><td align="center" colspan="2"><hr /></td></tr><tr><td align="left" rowspan="4">NMBA during maintenance (<svg height="6.20645pt" id="M7" style="vertical-align:-0.2063999pt" version="1.1" viewbox="-0.0498162 -6.00005 6.78059 6.20645" width="6.78059pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"><path d="M504 89L488 119C453 85 428 69 416 69C408 69 405 75 412 102L462 304C492 438 460 451 436 451S388 441 356 423C311 397 229 336 170 256H168L189 340C208 418 200 451 177 451C144 451 82 413 24 352L40 322C65 345 98 369 108 369C114 369 119 363 112 335L28 -3L36 -12C54 -3 83 4 112 10C125 73 138 122 153 174C205 258 328 382 376 382C395 382 399 369 384 305L330 93C312 25 323 -12 351 -12C378 -12 439 21 504 89Z" id="g50-111"></path><glyph.data ascent="3443" descent="-2856" horiz-adv-x="512" vert-adv-y="512"></glyph.data></g></svg>)</td><td align="left">Atracurium: 10</td></tr><tr><td align="left">Rocuronium: 2</td></tr><tr><td align="left">Vecuronium: 1</td></tr><tr><td align="left">Mivacurium: 1</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr" /></td></tr></table></td></tr></table></div></div>

Table 1 | Postoperative Residual Neuromuscular Paralysis at an Australian Tertiary Children’s Hospital

title

Table 1: Postoperative Residual Neuromuscular Paralysis at an Australian Tertiary Children’s Hospital

description

Table 1

About this journal

<p><em>Anesthesiology Research and Practice </em>provides a forum for health care professionals engaged in perioperative medicine, critical care, and pain management. Topics include anesthetic administration, preoperative and postoperative considerations etc.</p>


Journal profile

Meet the editorial board

<p><em>Anesthesiology Research and Practice </em>maintains an Editorial Board of practicing researchers from around the world, to ensure manuscripts are handled by editors who are experts in the field of study.</p>


Editor spotlight

Submit your proposal

Do you think there is an emerging area of research that really needs to be highlighted? Or an existing research area that has been overlooked or would benefit from deeper investigation? Raise the profile of a research area by leading a Special Issue.